Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp Investor Day Transcript

Sep 08, 2023 / 12:30PM GMT
Release Date Price: €67.5 (-2.17%)
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

And everybody hear me okay, over there? Well, we're waiting a minute or 2, I'll just kind of start babbling a little bit. This is our fourth at least my fourth investor conference, in fact, our fourth business. We didn't do anything 10 years ago externally. Earnings calls, anything. So they've all been fun and they've all grown every time we've done it. And we always are pretty transparent, and we're known for that. We try to be authentic. We're more or less a Midwestern culture still and we try to live by those values. You guys have all given us credit for that.

So today, we're going to talk about a lot of stuff. It is definitely a death march slide deck, sorry about that, but a lot in it. but it will be a good reference if nothing else. We are going to give our usual update on the 5 years, but we're going to actually talk about looking out 10 years even. So some of the new markets we're going into are -- they're going to be massive markets, but they take time to develop, things like liquid biopsy and selling gene therapy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot